Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 6,100 shares at $4.64 ($28K) on 2009-06-25, disclosed to the SEC on 2009-06-29.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 1,500 | $7K | 25.0% |
| 2 | $4.55 | 4,600 | $21K | 75.0% |
| Total | $4.57 avg | 6,100 | $28K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |